scispace - formally typeset
K

Kui Chen

Researcher at Chinese Academy of Sciences

Publications -  65
Citations -  949

Kui Chen is an academic researcher from Chinese Academy of Sciences. The author has contributed to research in topics: Medicine & Chemistry. The author has an hindex of 12, co-authored 54 publications receiving 535 citations. Previous affiliations of Kui Chen include Capital Normal University & Northeastern University (China).

Papers
More filters
Journal ArticleDOI

Oral administration of rutile and anatase TiO2 nanoparticles shifts mouse gut microbiota structure

TL;DR: Chronic overconsumption of TiO2 NP-containing foods is likely to deteriorate the gastrointestinal tract and change the structures of microbiota, and the crystalline phases may play an important role in mediating the intestinal impact of TiNPs.
Journal ArticleDOI

A Heterojunction Structured WO2.9-WSe2 Nanoradiosensitizer Increases Local Tumor Ablation and Checkpoint Blockade Immunotherapy upon Low Radiation Dose.

TL;DR: The results give potent evidence that local RT/PTT upon mild temperature and low radiation dose could efficiently ablate local tumors, inhibit tumor metastasis as well as prevent tumor re-challenge.
Journal ArticleDOI

Effect of quenching and tempering temperature on microstructure and tensile properties of microalloyed ultra-high strength suspension spring steel

TL;DR: In this paper, the effects of quenching-tempering heat treatment on microstructural evolution and fracture behavior of microalloyed high strength suspension spring 55SiCrVNb were investigated.
Journal ArticleDOI

The antihyperlipidemic effects of fullerenol nanoparticles via adjusting the gut microbiota in vivo

TL;DR: The two fullerenol NPs remarkably modulate the gut microbiota and selectively enrich SCFA-producing bacteria, which may be an important reason for their anti-hyperlipidemic effect in mice.
Journal ArticleDOI

Near infrared light triggered nitric oxide releasing platform based on upconversion nanoparticles for synergistic therapy of cancer stem-like cells

TL;DR: It is found that the combination of NO and chemotherapy could efficiently inhibit CSCs in bulk cells, including inhibiting mammosphere formation ability, decreasing CD44+/CD24− subpopulation and reducing tumorigenic ability.